by [email protected] | Nov 25, 2024 | CDT
1. Business Model Vulnerabilities Conduit Pharmaceuticals employs a unique model, acquiring Phase II-ready assets and seeking out-licensing deals after successful clinical trials. While innovative, this model introduces major risks: Dependence on Licensing Partners:...